24.06.2021 – 17:28Helmholtz Zentrum MünchenGastrulation research reveals novel details about embryonic developmentmehr
13.04.2021 – 14:04Fördergesellschaft IZB mbH2Lindis Biotech develops immunotherapy against bladder cancerIn the IZB you can find over 50 biotech start-upsEin Dokumentmehr
17.02.2021 – 13:00European Society for Medical Oncology (ESMO)Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground-Breaking Cancer Researchmehr
03.02.2021 – 13:30Fördergesellschaft IZB mbH3World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic toolsIn the IZB you can find over 50 biotech start-upsEin Dokumentmehr
19.10.2020 – 17:17Helmholtz Zentrum München4Novel medical imaging approach unlocks potential for improved diagnosis and interventionsLearn more about Helmholtz Pioneer Campusmehr
03.08.2020 – 17:12Helmholtz Zentrum MünchenAI & single-cell genomics: New software predicts cell fateVisit scVelo.orgmehr
03.02.2020 – 16:39Spectrum. The most dangerous artworkOn February 4 is World Cancer Day. German Cancer Aid and Dermatological Prevention Association demand: Sunbed Banmehr
23.01.2020 – 14:30Spectrum. The most dangerous artworkThe World's Most Dangerous Artwork / Cancer charity Deutsche Krebshilfe (German Cancer Aid), ADP, and the artistic duo LOW BROS welcomed guests to a somewhat unusual gallery openingmehr
06.11.2019 – 09:30Hitachi Medical Systems Europe Holding AG2Hitachi and Centre Léon Bérard cancer center in Lyon to launch a research collaboration in the fight against cancer with AImehr
21.10.2019 – 17:03Helmholtz Zentrum MünchenIdentification of a ferroptosis suppressor protein allows for new anticancer treatment approachRead more about Helmholtz Zentrum Münchenmehr
17.10.2019 – 17:34Fördergesellschaft IZB mbHThe development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZBIn the IZB you can find over 50 biotech start-upsEin Dokumentmehr
14.10.2019 – 17:27Helmholtz Zentrum MünchenDiscovery of potential novel therapeutic target for non-alcoholic fatty liver diseaseRead the papermehr
12.04.2019 – 11:45Helmholtz Zentrum München2CD30 - from witness to culpritMeldung hier online lesenmehr